The startup develops orthopedic surgical devices that employ a patented mechanism to create precise channels in bone for marrow stimulation therapy. This technology facilitates the healing of cartilage defects by promoting the body's natural repair processes in a minimally invasive manner.
Funding
$890K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional microfracture techniques for marrow stimulation therapy often result in inconsistent channel creation, excessive bone disruption, and limited access to stem cell-rich marrow, hindering effective cartilage regeneration. Existing methods like mallet microfracture and powered drilling can damage surrounding bone and nerve cells, or generate cell-damaging heat, respectively.
Solution
SmartShot is a surgical device designed to improve marrow stimulation therapy for cartilage defects. The device employs a patented mechanism to create precise, clean channels in bone, providing enhanced access to stem cell-rich marrow while minimizing disruption to the surrounding bone structure. This approach facilitates the body's natural healing processes in a minimally invasive manner, promoting more effective cartilage regeneration compared to traditional microfracture techniques. The SmartShot system includes a specific device tailored for addressing cartilage lesions in the ankle.
Target Audience
The primary target audience includes orthopedic surgeons specializing in sports medicine and cartilage restoration, particularly those seeking improved outcomes in marrow stimulation procedures for patients with cartilage defects.
Features
- Patented mechanism for creating precise and consistent channels in bone
- Provides 2X greater access to stem cell-rich marrow compared to legacy mallet microfracture
- Results in 66% less bone disruption compared to traditional microfracture
- Minimally invasive design reduces damage to surrounding tissues
- Dedicated SmartShot Ankle device designed for the unique challenges of treating cartilage lesions in the ankle
- Creates 1.5X more channels and 2X deeper penetration compared to mallet microfracture
- Does not cause subchondral compaction, unlike mallet microfracture